🇪🇺 ANAVEX2-73 oral liquid in European Union

ANAVEX2-73 oral liquid (ANAVEX2-73 oral liquid) regulatory status in European Union.

Marketing authorisation

EMA

  • Application: EMEA/H/C/006475
  • Local brand name: Blarcamesine Anavex
  • Indication: Treatment of Alzheimer’s disease and dementia.
  • Status: withdrawn

Read official source →

Other Neurology approved in European Union

Frequently asked questions

Is ANAVEX2-73 oral liquid approved in European Union?

Yes. EMA has authorised it.

Who is the marketing authorisation holder for ANAVEX2-73 oral liquid in European Union?

Anavex Life Sciences Corp. is the originator. The local marketing authorisation holder may differ — check the official source linked above.